8:45am ET
Investing
Elon Musk Leads Insider Buying Wave
The highlight of recent insider buying is an enormous purchase of Tesla shares by CEO Elon Musk. But it wasn't the only notable buy in the past week or so.
Companies
/Healthcare
Cg Oncology Inc
$72.00
▲ $0.04 (+0.06%) today
Markets closed · 9:38pm ET
Today · % change
Fundamentals
Market Cap
$6.4B
Revenue (TTM)
$6.2M
EPS (TTM)
$-2.69
52-Week Range
$33 – $81
Street Target
$91.08
About CG Oncology
CG Oncology, Inc., originally Cold Genesys, Inc., is a pioneering firm in oncolytic immunotherapy, focusing on innovative treatments for bladder cancer. Based in Irvine, California since 2010, the company is dedicated to creating therapies that aim to preserve the bladder in patients with various stages of bladder cancer. Their portfolio includes treatments like BOND-003, CORE-001, and CORE-002, targeting high-risk and muscle invasive bladder cancer, alongside therapies for intermediate-risk patients. CG Oncology is at the forefront of combining their treatments with other cancer therapies to enhance patient outcomes.
CGON Coverage
12:09pm ET
Investing
Insider Buying at These Biotechs Is Huge
As January wound to a close, beneficial owners, executives, and other insiders took advantage of public offerings of stock at these biotech companies.